{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:14:54Z","timestamp":1793297694445,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2016R1D1A1B01010316"],"award-info":[{"award-number":["2016R1D1A1B01010316"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s10120-020-01059-3","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T17:03:50Z","timestamp":1584983030000},"page":"780-795","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Epstein\u2013Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3\/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas"],"prefix":"10.1007","volume":"23","author":[{"given":"Chan Jin","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0948-799X","authenticated-orcid":false,"given":"Mee Soo","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Ha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Kyung","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Cheol","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Hee","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"key":"1059_CR1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"LS Young","year":"2004","unstructured":"Young LS, Rickinson AB. Epstein\u2013Barr virus: 40 years on. Nat Rev Cancer. 2004;4:757\u201368.","journal-title":"Nat Rev Cancer"},{"key":"1059_CR2","first-page":"1898","volume-title":"Fields virology","author":"RM Longnecker","year":"2013","unstructured":"Longnecker RM, Kieff E, Cohen JI. Epstein\u2013Barr virus. In: Knipe DM, Howley PM, editors. Fields virology. 6th ed. Philadelphia: Lippincott-Williams and Wilkins; 2013. p. 1898\u20131959.","edition":"6"},{"key":"1059_CR3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4143\/crt.2018.143","volume":"50","author":"KW Jung","year":"2018","unstructured":"Jung KW, Won YJ, Kong HJ, Lee ES. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat. 2018;50:303\u201316.","journal-title":"Cancer Res Treat"},{"key":"1059_CR4","doi-asserted-by":"crossref","first-page":"10515","DOI":"10.1128\/JVI.00955-13","volume":"87","author":"MS Chang","year":"2013","unstructured":"Chang MS, Kim DH, Roh JK, Middeldorp JM, Kim YS, Kim S, et al. Epstein\u2013Barr virus-encoded BARF1 promotes proliferation of gastric carcinoma cells through regulation of NF-\u03baB. J Virol. 2013;87:10515\u201323.","journal-title":"J Virol"},{"key":"1059_CR5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202\u20139.","journal-title":"Nature"},{"key":"1059_CR6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21:449\u201356.","journal-title":"Nat Med"},{"key":"1059_CR7","doi-asserted-by":"crossref","first-page":"e1003341","DOI":"10.1371\/journal.ppat.1003341","volume":"9","author":"MJ Strong","year":"2013","unstructured":"Strong MJ, Xu G, Coco J, Baribault C, Vinay DS, Lacey MR, et al. Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy. PLoS Pathog. 2013;9:e1003341.","journal-title":"PLoS Pathog"},{"key":"1059_CR8","doi-asserted-by":"crossref","first-page":"e0182692","DOI":"10.1371\/journal.pone.0182692","volume":"12","author":"L Gu","year":"2017","unstructured":"Gu L, Chen M, Guo D, Zhu H, Zhang W, Pan J, et al. PD-L1 and gastric cancer prognosis: a systematic review and meta-analysis. PLoS ONE. 2017;12:e0182692.","journal-title":"PLoS ONE"},{"key":"1059_CR9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.virol.2009.01.006","volume":"386","author":"ZL Pratt","year":"2009","unstructured":"Pratt ZL, Kuzembayeva M, Sengupta S, Sugden B. The microRNAs of Epstein\u2013Barr virus are expressed at dramatically differing levels among cell lines. Virology. 2009;386:387\u201397.","journal-title":"Virology"},{"key":"1059_CR10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1096781","volume":"304","author":"S Pfeffer","year":"2004","unstructured":"Pfeffer S, Zavolan M, Gr\u00e4sser FA, Chien M, Russo JJ, Ju J, et al. Identification of virus-encoded microRNAs. Science. 2004;304:734\u20136.","journal-title":"Science"},{"key":"1059_CR11","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1128\/JVI.02662-13","volume":"88","author":"AR Marquitz","year":"2014","unstructured":"Marquitz AR, Mathur A, Chugh PE, Dittmer DP, Raab-Traub N. Expression profile of microRNAs in Epstein\u2013Barr virus-infected AGS gastric carcinoma cells. J Virol. 2014;88:1389\u201393.","journal-title":"J Virol"},{"key":"1059_CR12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1128\/JVI.02271-06","volume":"81","author":"DN Kim","year":"2007","unstructured":"Kim DN, Chae HS, Oh ST, Kang JH, Park CH, Park WS, et al. Expression of viral microRNAs in Epstein\u2013Barr virus-associated gastric carcinoma. J Virol. 2007;81:1033\u20136.","journal-title":"J Virol"},{"key":"1059_CR13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/ijms17040538","volume":"17","author":"TB Fl\u00f3r","year":"2016","unstructured":"Fl\u00f3r TB, Blom B. Pathogens use and abuse microRNAs to deceive the immune system. Int J Mol Sci. 2016;17:538.","journal-title":"Int J Mol Sci"},{"key":"1059_CR14","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1084\/jem.20072581","volume":"205","author":"EY Choy","year":"2008","unstructured":"Choy EY, Siu KL, Kok KH, Lung RW, Tsang CM, To KF, et al. An Epstein\u2013Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med. 2008;205:2551\u2013600.","journal-title":"J Exp Med"},{"key":"1059_CR15","first-page":"e01022","volume":"92","author":"X Zheng","year":"2018","unstructured":"Zheng X, Wang J, Wei L, Peng Q, Gao Y, Fu Y, et al. Epstein\u2013Barr virus microRNA miR-BART5-3p inhibits p53 expression. J Virol. 2018;92:e01022\u201318.","journal-title":"J Virol"},{"key":"1059_CR16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.canlet.2014.10.023","volume":"356","author":"H Kim","year":"2015","unstructured":"Kim H, Choi H, Lee SK. Epstein\u2013Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD. Cancer Lett. 2015;356:733\u201342.","journal-title":"Cancer Lett"},{"key":"1059_CR17","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1128\/JVI.03159-12","volume":"87","author":"H Choi","year":"2013","unstructured":"Choi H, Lee H, Kim SR, Gho YS, Lee SK. Epstein\u2013Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. J Virol. 2013;87:8135\u201344.","journal-title":"J Virol"},{"key":"1059_CR18","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1038\/ncomms8353","volume":"6","author":"L Cai","year":"2015","unstructured":"Cai L, Ye Y, Jiang Q, Chen Y, Lyu X, Li Z, et al. Epstein\u2013Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma. Nat Commun. 2015;6:7353.","journal-title":"Nat Commun"},{"key":"1059_CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijc.28007","volume":"133","author":"T Lei","year":"2013","unstructured":"Lei T, Yuen KS, Xu R, Tsao SW, Chen H, Li M, et al. Targeting of DICE1 tumor suppressor by Epstein\u2013Barr virus-encoded miR-BART3 microRNA in nasopharyngeal carcinoma. Int J Cancer. 2013;133:79\u2013877.","journal-title":"Int J Cancer"},{"key":"1059_CR20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1159\/000479749","volume":"9","author":"Y Lu","year":"2017","unstructured":"Lu Y, Qin Z, Wang J, Zheng X, Lu J, Zhang X, et al. Epstein\u2013Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway. J Innate Immun. 2017;9:574\u201386.","journal-title":"J Innate Immun"},{"key":"1059_CR21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s13046-018-0953-6","volume":"37","author":"C Lin","year":"2018","unstructured":"Lin C, Zong J, Lin W, Wang M, Xu Y, Zhou R, et al. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-\u03baB and Erk1\/2 pathways. J Exp Clin Cancer Res. 2018;37:283.","journal-title":"J Exp Clin Cancer Res"},{"key":"1059_CR22","doi-asserted-by":"crossref","first-page":"e1003974","DOI":"10.1371\/journal.ppat.1003974","volume":"10","author":"CY Hsu","year":"2014","unstructured":"Hsu CY, Yi YH, Chang KP, Chang YS, Chen SJ, Chen HC. The Epstein\u2013Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma. PLoS Pathog. 2014;10:e1003974.","journal-title":"PLoS Pathog"},{"key":"1059_CR23","doi-asserted-by":"crossref","first-page":"41766","DOI":"10.18632\/oncotarget.6155","volume":"6","author":"Q Yan","year":"2015","unstructured":"Yan Q, Zeng Z, Gong Z, Zhang W, Li X, He B, et al. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC. Oncotarget. 2015;6:41766\u201382.","journal-title":"Oncotarget"},{"key":"1059_CR24","doi-asserted-by":"crossref","first-page":"82213","DOI":"10.18632\/oncotarget.10511","volume":"7","author":"DH Kim","year":"2016","unstructured":"Kim DH, Chang MS, Yoon CJ, Middeldorp JM, Martinez OM, Byeon SJ, et al. Epstein\u2013Barr virus BARF1-induced NF\u03baB\/miR-146a\/SMAD4 alterations in stomach cancer cells. Oncotarget. 2016;7:82213\u201327.","journal-title":"Oncotarget"},{"key":"1059_CR25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","volume":"19","author":"BM Bolstad","year":"2003","unstructured":"Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185\u201393.","journal-title":"Bioinformatics"},{"key":"1059_CR26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/07357900903095730","volume":"28","author":"JY Jeong","year":"2010","unstructured":"Jeong JY, Woo JH, Kim YS, Choi S, Lee SO, Kil SR, et al. Nuclear factor-kappa B inhibition reduces markedly cell proliferation in Epstein\u2013Barr virus-infected stomach cancer, but affects variably in Epstein\u2013Barr virus-negative stomach cancer. Cancer Investig. 2010;28:113\u20139.","journal-title":"Cancer Investig"},{"key":"1059_CR27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.molonc.2011.03.004","volume":"5","author":"A Kluge","year":"2011","unstructured":"Kluge A, Dabir S, Vlassenbroeck I, Eisenberg R, Dowlati A. Protein inhibitor of activated STAT3 expression in lung cancer. Mol Oncol. 2011;5:256\u201364.","journal-title":"Mol Oncol"},{"key":"1059_CR28","doi-asserted-by":"crossref","first-page":"e12745","DOI":"10.1371\/journal.pone.0012745","volume":"5","author":"SJ Chen","year":"2010","unstructured":"Chen SJ, Chen GH, Chen YH, Liu CY, Chang KP, Chang YS, et al. Characterization of Epstein\u2013Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS ONE. 2010;5:e12745.","journal-title":"PLoS ONE"},{"key":"1059_CR29","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.compbiomed.2011.07.007","volume":"41","author":"SG Babu","year":"2011","unstructured":"Babu SG, Ponia SS, Kumar D, Saxena S. Cellular oncomiR orthologue in EBV oncogenesis. Comput Biol Med. 2011;41:891\u20138.","journal-title":"Comput Biol Med"},{"key":"1059_CR30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/bjc.2012.587","volume":"108","author":"W Wu","year":"2013","unstructured":"Wu W, Takanashi M, Borjigin N, Ohno SI, Fujita K, Hoshino S, et al. MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis. Br J Cancer. 2013;108:653\u201361.","journal-title":"Br J Cancer"},{"key":"1059_CR31","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1126\/science.278.5344.1803","volume":"278","author":"CD Chung","year":"1997","unstructured":"Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, et al. Specific inhibition of Stat3 signal transduction by PIAS3. Science. 1997;278:1803\u20135.","journal-title":"Science"},{"key":"1059_CR32","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","volume":"435","author":"L He","year":"2005","unstructured":"He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005;435:828\u201333.","journal-title":"Nature"},{"key":"1059_CR33","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2007-11-123141","volume":"111","author":"T Azuma","year":"2008","unstructured":"Azuma T, Yao S, Zhu G, Flies AS, Slier SJ, Chen L, et al. B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. Blood. 2008;111:3635\u201343.","journal-title":"Blood"},{"key":"1059_CR34","doi-asserted-by":"crossref","first-page":"20852","DOI":"10.1073\/pnas.0810958105","volume":"105","author":"M Marzec","year":"2008","unstructured":"Marzec M, Zhang Q, Goradia A, Raghunath PN, Liu X, Paessler M, et al. Oncogenic kinase NPM\/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1). Proc Natl Acad Sci USA. 2008;105:20852\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1059_CR35","doi-asserted-by":"crossref","first-page":"eaav4810","DOI":"10.1126\/scitranslmed.aav4810","volume":"11","author":"A Prestipino","year":"2019","unstructured":"Prestipino A, Zeiser R. Clinical implications of tumor-intrinsic mechanisms regulating PD-L1. Sci Transl Med. 2019;11:eaav4810.","journal-title":"Sci Transl Med"},{"key":"1059_CR36","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1159\/000460504","volume":"41","author":"J Li","year":"2017","unstructured":"Li J, Chen L, Xiong Y, Zheng X, Xie Q, Zhou Q, et al. Knockdown of PD-L1 in human gastric cancer cells inhibits tumor progression and improves the cytotoxic sensitivity to CIK therapy. Cell Physiol Biochem. 2017;41:907\u201320.","journal-title":"Cell Physiol Biochem"},{"key":"1059_CR37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12:252\u201364.","journal-title":"Nat Rev Cancer"},{"key":"1059_CR38","doi-asserted-by":"crossref","first-page":"e1433520","DOI":"10.1080\/2162402X.2018.1433520","volume":"7","author":"L Ying","year":"2018","unstructured":"Ying L, Yan F, Meng Q, Yu L, Yuan X, Gantier MP, et al. PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers. Oncoimmunology. 2018;7:e1433520.","journal-title":"Oncoimmunology"},{"key":"1059_CR39","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1186\/s12885-015-1813-9","volume":"15","author":"X Liu","year":"2015","unstructured":"Liu X, Liu J, Qiu H, Kong P, Chen S, Li W, et al. Prognostic significance of Epstein\u2013Barr virus infection in gastric cancer: a meta-analysis. BMC Cancer. 2015;15:782.","journal-title":"BMC Cancer"},{"key":"1059_CR40","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/humu.22014","volume":"33","author":"W Wang","year":"2012","unstructured":"Wang W, Sun J, Li F, Li R, Gu Y, Liu C, et al. A frequent somatic mutation in CD274 3-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding. Hum Mutat. 2012;33:480\u20134.","journal-title":"Hum Mutat"},{"key":"1059_CR41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10120-016-0631-3","volume":"20","author":"A Kawazoe","year":"2017","unstructured":"Kawazoe A, Kuwata T, Kuboki Y, Shitara K, Nagatsuma AK, Aizawa M, et al. Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein\u2013Barr virus status in a large cohort of gastric cancer patients. Gastric Cancer. 2017;20:407\u201315.","journal-title":"Gastric Cancer"},{"key":"1059_CR42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2326","volume":"8","author":"W Zou","year":"2008","unstructured":"Zou W, Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol. 2008;8:467\u201377.","journal-title":"Nat Rev Immunol"},{"key":"1059_CR43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.it.2010.01.005","volume":"31","author":"Z Yagil","year":"2010","unstructured":"Yagil Z, Nechushtan H, Kay G, Yang CM, Kemeny DM, Razin E. The enigma of the role of protein inhibitor of activated STAT3 (PIAS3) in the immune response. Trends Immunol. 2010;31:199\u2013204.","journal-title":"Trends Immunol"},{"key":"1059_CR44","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1038\/sj.onc.1203476","volume":"19","author":"J Bromberg","year":"2000","unstructured":"Bromberg J, Darnell JE Jr. The role of STATs in transcriptional control and their impact on cellular function. Oncogene. 2000;19:2468\u201373.","journal-title":"Oncogene"},{"key":"1059_CR45","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","volume":"14","author":"H Yu","year":"2014","unstructured":"Yu H, Lee H, Hermann A, Buettner R, Jove R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer. 2014;14:736\u201346.","journal-title":"Nat Rev Cancer"},{"key":"1059_CR46","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","volume":"48","author":"C Sun","year":"2018","unstructured":"Sun C, Mezzadra R, Schumacher TN. Regulation and function of the PD-L1 checkpoint. Immunity. 2018;48:434\u201352.","journal-title":"Immunity"},{"key":"1059_CR47","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1038\/s41388-018-0303-3","volume":"37","author":"I Zerdes","year":"2018","unstructured":"Zerdes I, Matikas A, Bergh J, Rassidakis GZ, Foukakis T. Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations. Oncogene. 2018;37:4639\u201361.","journal-title":"Oncogene"},{"key":"1059_CR48","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1074\/jbc.C600321200","volume":"282","author":"XO Yang","year":"2007","unstructured":"Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem. 2007;282:9358\u201363.","journal-title":"J Biol Chem"},{"key":"1059_CR49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-4939-6655-4_9","volume":"1532","author":"RL Skalsky","year":"2017","unstructured":"Skalsky RL. Analysis of viral and cellular microRNAs in EBV-infected cells. Methods Mol Biol. 2017;1532:133\u201346.","journal-title":"Methods Mol Biol"},{"key":"1059_CR50","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1158\/0008-5472.CAN-11-3919","volume":"72","author":"A Kaneda","year":"2012","unstructured":"Kaneda A, Matsusaka K, Aburatani H, Fukayama M. Epstein\u2013Barr virus infection as an epigenetic driver of tumorigenesis. Cancer Res. 2012;72:3445\u2013500.","journal-title":"Cancer Res"},{"key":"1059_CR51","doi-asserted-by":"crossref","first-page":"e0136058","DOI":"10.1371\/journal.pone.0136058","volume":"10","author":"D Pandya","year":"2015","unstructured":"Pandya D, Mariani M, He S, Andreoli M, Spennato M, Dowell-Martino C, et al. Epstein\u2013Barr virus microRNA expression increases aggressiveness of solid malignancies. PLoS ONE. 2015;10:e0136058.","journal-title":"PLoS ONE"},{"key":"1059_CR52","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12935-018-0637-5","volume":"18","author":"JJ Jing","year":"2018","unstructured":"Jing JJ, Wang ZY, Li H, Sun LP, Yuan Y. Key elements involved in Epstein\u2013Barr virus-associated gastric cancer and their network regulation. Cancer Cell Int. 2018;18:146.","journal-title":"Cancer Cell Int"},{"key":"1059_CR53","doi-asserted-by":"crossref","first-page":"e1002193","DOI":"10.1371\/journal.ppat.1002193","volume":"7","author":"J Qiu","year":"2011","unstructured":"Qiu J, Cosmopoulos K, Pegtel M, Hopmans E, Murray P, Middeldorp J, et al. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog. 2011;7:e1002193.","journal-title":"PLoS Pathog"},{"key":"1059_CR54","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1128\/JVI.03639-14","volume":"89","author":"A Shinozaki-Ushiku","year":"2015","unstructured":"Shinozaki-Ushiku A, Kunita A, Isogai M, Hibiya T, Ushiku T, Takada K, et al. Profiling of virus-encoded microRNAs in Epstein\u2013Barr virus-associated gastric carcinoma and their roles in gastric carcinogenesis. J Virol. 2015;89:5581\u201391.","journal-title":"J Virol"},{"key":"1059_CR55","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/jgh.13432","volume":"32","author":"CY Tsai","year":"2017","unstructured":"Tsai CY, Liu YY, Liu KH, Hsu JT, Chen TS, Chiu CT, et al. Comprehensive profiling of virus microRNAs of Epstein\u2013Barr virus-associated gastric carcinoma: highlighting the interactions of ebv-Bart9 and host tumor cells. J Gastroenterol Hepatol. 2017;32:82\u201391.","journal-title":"J Gastroenterol Hepatol"},{"key":"1059_CR56","doi-asserted-by":"crossref","first-page":"e1004561","DOI":"10.1371\/journal.ppat.1004561","volume":"11","author":"J Qiu","year":"2015","unstructured":"Qiu J, Smith P, Leahy L, Thorley-Lawson DA. The Epstein\u2013Barr virus encoded BART miRNAs potentiate tumor growth in vivo. PLoS Pathog. 2015;11:e1004561.","journal-title":"PLoS Pathog"},{"key":"1059_CR57","doi-asserted-by":"crossref","first-page":"e1004979","DOI":"10.1371\/journal.ppat.1004979","volume":"11","author":"D Kang","year":"2015","unstructured":"Kang D, Skalsky RL, Cullen BR. EBV BART microRNAs target multiple pro-apoptotic cellular genes to promote epithelial cell survival. PLoS Pathog. 2015;11:e1004979.","journal-title":"PLoS Pathog"},{"key":"1059_CR58","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/JVI.03189-14","volume":"89","author":"T Kanda","year":"2015","unstructured":"Kanda T, Miyata M, Kano M, Kondo S, Yoshizaki T, Iizasa H. Clustered microRNAs of the Epstein\u2013Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor. J Virol. 2015;89:2684\u201397.","journal-title":"J Virol"},{"key":"1059_CR59","doi-asserted-by":"crossref","first-page":"e1001294","DOI":"10.1371\/journal.ppat.1001294","volume":"7","author":"R Feederle","year":"2011","unstructured":"Feederle R, Linnstaedt SD, Banner H, Lips H, Bencun M, Cullen BR, et al. A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog. 2011;7:e1001294.","journal-title":"PLoS Pathog"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-020-01059-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-020-01059-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-020-01059-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T01:09:24Z","timestamp":1616461764000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-020-01059-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1007\/s10120-020-01059-3","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]},"assertion":[{"value":"4 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that no conflict of interests exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study protocol was reviewed and approved by the Institutional Review Board of the Seoul National University Boramae Hospital under conditions of anonymity (IRB No. 20140204\/26-2014-13\/022). All human tissue specimens were obtained during diagnostic and therapeutic surgery. This study was performed using the stored paraffin blocks containing tissue samples after the pathologic diagnosis, and all of the samples were anonymized before the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Complying with the Bioethics and Safety act fully revised and effective February 1, 2013 in Republic of Korea, participants undergone surgery after February 1, 2013 are supposed to provide the informed consent for the study using paraffin block-embedded tissues. In this study, the patients undergone surgery before February 1, 2013 did not submit the informed consent according to the Bioethics and Safety act of the time.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}